Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Fixa

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Casopis Lekaru Ceskych|July 18, 1986
[Pulmonary diffusing capacity disorder in nonspecific intestinal inflammations unexplainable by acetylation phenotype or treatment with sulfasalazine]J Bures, J Horácek, P Tilser, et al.
Vnitrni Lekarstvi|February 1, 1994
[Thrombocytes as an indicator of activity in Crohn's disease treated with total parenteral and/or enteral nutrition]J Bures, J Horácek, M Pecka, et al.
Vnitrni Lekarstvi|July 1, 1985
[Colicinogeny in colorectal cancer]J Bures, V Horák, B Fixa, et al.
Casopis Lekaru Ceskych|September 14, 1990
[Excretion of phenol and p-cresol in the urine in fasting obese individuals and in persons treated with total enteral nutrition]J Bures, Z Jergeová, L Sobotka, et al.
Sbornik Vedeckych Praci Lekarske Fakulty Karlovy University V Hradci Kralove|January 1, 1993
Immunoglobulin G subclasses in Crohn's disease with and without bowel resectionJ Bures, M Tichý, J Horácek, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|July 1, 1981
[Diagnosis of rejection]P Fixa, J Erben, B Fixa, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2006
Comparison of the efficacy and safety of Eudragit-L-coated mesalazine tablets with ethylcellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitisP R Gibson, B Fixa, B Pekárková, et al.
Alimentary Pharmacology & Therapeutics|February 1, 2005
A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitisY Marakhouski, B Fixa, J Holomán, et al.
Gut|October 14, 2004
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazineW Kruis, P Fric, J Pokrotnieks, et al.
Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity V Hradci Kralove. Supplementum|January 1, 1976
[Prognosis of rejection of cadaveric transplant kidney after a 5-year experience]J Erben, J Base, Z Jerábek, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Casopis Lekaru Ceskych|July 18, 1986
[Pulmonary diffusing capacity disorder in nonspecific intestinal inflammations unexplainable by acetylation phenotype or treatment with sulfasalazine]J Bures, J Horácek, P Tilser, et al.
Vnitrni Lekarstvi|February 1, 1994
[Thrombocytes as an indicator of activity in Crohn's disease treated with total parenteral and/or enteral nutrition]J Bures, J Horácek, M Pecka, et al.
Vnitrni Lekarstvi|July 1, 1985
[Colicinogeny in colorectal cancer]J Bures, V Horák, B Fixa, et al.
Casopis Lekaru Ceskych|September 14, 1990
[Excretion of phenol and p-cresol in the urine in fasting obese individuals and in persons treated with total enteral nutrition]J Bures, Z Jergeová, L Sobotka, et al.
Sbornik Vedeckych Praci Lekarske Fakulty Karlovy University V Hradci Kralove|January 1, 1993
Immunoglobulin G subclasses in Crohn's disease with and without bowel resectionJ Bures, M Tichý, J Horácek, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|July 1, 1981
[Diagnosis of rejection]P Fixa, J Erben, B Fixa, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2006
Comparison of the efficacy and safety of Eudragit-L-coated mesalazine tablets with ethylcellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitisP R Gibson, B Fixa, B Pekárková, et al.
Alimentary Pharmacology & Therapeutics|February 1, 2005
A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitisY Marakhouski, B Fixa, J Holomán, et al.
Gut|October 14, 2004
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazineW Kruis, P Fric, J Pokrotnieks, et al.
Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity V Hradci Kralove. Supplementum|January 1, 1976
[Prognosis of rejection of cadaveric transplant kidney after a 5-year experience]J Erben, J Base, Z Jerábek, et al.
Pageof 9